[1]
2022. RELATIONSHIP BETWEEN VISFATIN AND SOME BIOMARKERS OF BONE TURNOVER IN PATIENTS WITH CHRONIC KIDNEY DISEASE. MEDIS – International Journal of Medical Sciences and Research. 1, 3 (Sep. 2022), 31–36. DOI:https://doi.org/10.35120/medisij010331p.